Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Syngene's collaboration with Zoetis started in 2011
Mamilli last held the role of Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health at Zoetis
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
Profit after tax (before exceptional items) up 23% to Rs 215 crores
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
The company is pleased to report positive performances from all divisions this quarter. Growth in our research divisions, Discovery Services and the Dedicated Centres was solid
Revenue from operations up 26% to Rs. 768 crores
The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind
A special purpose vehicle (SPV) formed by O2 Energy SG Pte Ltd, for generation and supply of renewable power
Subscribe To Our Newsletter & Stay Updated
